Eli Lilly's Alzheimer's drug donanemab can slow disease: Study
Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.
Source: newswest9.com
Page 27 - John Sims News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Sims. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Sims Today - Breaking & Trending Today
Second Alzheimer's drug can slow disease by a few months
Another experimental Alzheimer's drug can modestly slow patients' inevitable worsening — by about four to seven months, researchers reported Monday.
Source: stltoday.com
2nd Alzheimer's drug in pipeline can slow the disease by a few months but with safety risk
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening. Patients given monthly infusions of Eli Lilly and Co.'s donanemab declined about four to seven months more
Source: smdailyjournal.com
Regulators urged to approve game-changing new Alzheimer's drug that slows decline by up to 60% amid hope donanemab could be on the NHS in two years
Brits should be able to get the new Alzheimer's drug donanemab which can slow the disease to a crawl in the next two years with experts urging regulators to do all they can to approve the treatment.
Source: dailymail.co.uk
Second Alzheimer's drug in pipeline can slow the disease by a few months
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening. Patients given monthly infusions of Eli Lilly and Co.'s donanemab declined about four to seven months more
Source: messenger-inquirer.com